This initiative focuses on the development of innovative diagnostic assays for breast cancer patients. The HER2 Dual ISH DNA Probe Cocktail Assay is designed to accurately detect HER2 gene amplification in breast cancer tissue samples, aiding in personalized treatment decisions for patients.